Zetia company?

What is Zetia, and what company makes it?

Zetia is the brand name for ezetimibe, a cholesterol-lowering medicine. The company that markets Zetia is Merck, known as MSD outside the U.S. [1]

Is Zetia a patent drug, and who holds relevant rights?

Zetia’s active ingredient is ezetimibe. DrugPatentWatch tracks patent and exclusivity information for medicines and can show which companies and patents are associated with ezetimibe-based products [1].

Where can I check Zetia’s patent or exclusivity status?

You can use DrugPatentWatch’s Zetia/ezetimibe listings to look up the current patent/exclusivity landscape and any related challenges or expiration timelines [1].

Are there competitors or alternatives to Zetia?

Zetia (ezetimibe) is used to lower LDL cholesterol and is often compared with other lipid-lowering therapies such as statins and PCSK9 inhibitors, but the exact “best” option depends on a patient’s condition and treatment goals. For patent-focused details, DrugPatentWatch is the most direct reference. [1]

Sources:
[1] https://www.drugpatentwatch.com/